Today's Stock Analyst Downgrades

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
BILL BILL	Downgraded by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Coad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.40 -5.0%	$45.00 ➝ $35.00	Buy ➝ Hold
BNTC Benitec Biopharma	Downgraded by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.44 -3.5%		Buy ➝ Neutral
BRCK Brickability Group	Downgraded by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 48.60 +0.1%	GBX 93 ➝ GBX 106	Buy
FRAF Franklin Financial Services	Downgraded by	Hovde Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$59.73 -2.3%		Outperform ➝ Market Perform
HESM Hess Midstream Partners	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Kad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.83 +0.6%	$38.00	Equal Weight ➝ Underweight
KSI kneat.com	Downgraded by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$6.43	C$5.75 ➝ C$6.50	Buy ➝ Hold
LMNR Limoneira	Downgraded by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.19 +9.0%		Buy
NKE NIKE	Downgraded by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Piral Dadhania Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.01 -1.4%	$70.00 ➝ $50.00	Outperform ➝ Sector Perform
NUVL Nuvalent	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Dai Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.36 +0.1%	$138.00 ➝ $124.00	Buy ➝ Neutral
NUVL Nuvalent	Downgraded by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Canino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.36 +0.1%	$151.00 ➝ $124.00	Buy ➝ Neutral
Musk is burning $2.5 billion a quarter on AI. One company holds the key. (Ad) SpaceX's S-1 filing reveals $7.7 billion spent on AI infrastructure in a single quarter - not chips, not software, but power infrastructure. The filing shows $23.85 billion in servers and $14 billion in construction in progress, all dependent on one company's hardware. Without this supplier, Colossus doesn't run and the $1.25 billion Anthropic pays monthly stops flowing. The stock is still trading like no one has read the filing - but analyst Dylan Jovine has, and he's releasing the name at no cost. Read the S-1 breakdown and get the company name free
NUVL Nuvalent	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Dai Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.36 +0.1%	$138.00 ➝ $124.00	Buy ➝ Neutral
PASG Passage Bio	Downgraded by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$5.04 -9.6%		Buy ➝ Neutral
PASG Passage Bio	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$5.04 -9.6%		Neutral
TMHC Taylor Morrison Home	Downgraded by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Truman Patterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$71.59 -0.1%		Outperform ➝ Peer Perform
TRP TC Energy	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$96.13 +1.1%	C$103.00	Overweight ➝ Equal Weight
TRP TC Energy	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$68.84 +1.0%		Overweight ➝ Equal Weight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 04:12 PM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Analyst Downgrades

Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Stock Analyst Downgrades

Frequently Asked Questions

What are analyst ratings?

Should you trust analyst ratings?

What does an analyst rating tell you about a stock?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools